- Press Release Distribution

Studies help explain why some prostate cancers become resistant to hormone therapy

UCLA-led research lays the groundwork for developing improved therapies for treatment-resistant prostate tumors

( Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow — advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease.

Hormone therapy, also known as antiandrogen therapy, plays a crucial role in temporarily halting the growth of prostate cancer cells. Over time, however, the majority of patients eventually see their cancer return and progress, underscoring the pressing need for continued advancements to enhance clinical outcomes.

“Identifying metabolic alterations and understanding patterns in cancer cells could be a critical component to developing new cancer treatments,” said Andrew Goldstein, associate professor of molecular, cell and developmental biology and urology at the David Geffen School of Medicine at UCLA and member of the UCLA Jonsson Comprehensive Cancer Center. “New technological advances are giving us insight into actually how these tumors are breaking down their nutrients — known as cancer metabolism — to help them grow. And we might be able to harness or exploit that biology to make tumors more treatable.”

Metabolic insights reveal treatment sensitivity and resistance pathways

In the first study, published today in Nature Cell Biology, the team of investigators identified a specific process in prostate cells that helps determine how they evolve from one type of cell to another, which plays a crucial role in determining a response to treatment.

There are two types of cells in the prostate: basal and luminal cells. Whether cancer initially starts in a basal cell or a luminal cell, it almost always takes on the properties of luminal cells as the cancer grows. But over time, and in response to treatment, some tumors become less luminal. When a tumor is very luminal, it is more treatable using hormone therapy. And when it's less luminal, it's less treatable and more resistant, noted Goldstein, who is the senior author of the study and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

While studying this process, researchers saw that when basal cells transform into luminal cells, the way they process a molecule called pyruvate changes. These changes in metabolism can influence the “genetic instructions” within the cells that determine how they develop and respond to treatment.

The team discovered that blocking a specific part of cell metabolism, called the mitochondrial pyruvate carrier, and adding a substance called lactate can change the cell behavior. These changes could potentially affect the success of treatments for prostate cancer, especially those targeting the androgen receptor, a key player in prostate cancer growth.

Additionally, altering how cells use a substance called lactate can cause significant changes in how the DNA is organized in the cells, affecting which genes are turned on or off.

“The study highlights the importance of considering how altering cell metabolism could impact prostate cancer and its response to treatment,” said first author of the study Jenna Giafaglione, a graduate student in UCLA’s Molecular Biology Interdepartmental Program and member of the Goldstein lab as well as the lab of Paul Boutros, director of cancer data science at the UCLA Jonsson Comprehensive Cancer Center. “If we know that certain aspects of metabolism are promoting a resistant phenotype, then we can go after new targets in those resistant tumors.”

MYC protein identified as key regulator

The second study, published in the journal Cell Reports, sheds new light into how prostate cancer cells react when the androgen receptor pathway is blocked, which is a common approach in treating advanced prostate cancer.

To understand what happens to the cell's energy production and usage in response to this blocking, Goldstein and his team looked at how the cancer cells change the way they produce energy. They found that cells start out depending on a type of energy inside the mitochondria, pinpointing certain molecules and processes within the cell that control these changes.

One important protein in this process, called MYC, was found to be the critical regulator of the behavior. Specifically, they saw that if MYC activity decreases as a consequence of the therapy, then these cells seem to become very reliant on their mitochondria to survive. If MYC does not go down, then the cells are much more resilient and resistant to therapy, and not reliant on their mitochondria. Boosting MYC activity reversed the changes in energy production, making the cancer cells less sensitive to certain inhibitors.

“This study teaches us about treatment response and also suggests that if we could find the right combination of therapies, for example, to use hormone therapy initially, and then to use some kind of secondary therapy that influences the mitochondrial behavior, we might be able to reduce disease progression and recurrence,” Goldstein said.

Taken together, the new studies demonstrate a need to further study the link between metabolism and treatment resistance or treatment response. Understanding and controlling these changes could potentially help develop better treatments for prostate cancer.


Funding: The study appearing in Nature Cell Biology is supported in part by grants from National Institutes of Health, the UCLA Prostate Cancer Specialized Programs of Research Excellence (SPORE), The American Cancer Society, the U.S. Department of Defense and the Hutton Family Foundation.

Other UCLA authors include: Preston Crowell, Amelie Delcourt, Takao Hashimoto, Sung Min Ha, Aishwarya Atmakuri, Nicholas Nunley, Rachel Dang, Mao Tian, Johnny Diaz, Marie Payne, Neil Lin and Paul Boutros.

Funding: The study appearing in Cell Reports is supported in part by grants from National Institutes of Health, the UCLA Prostate Cancer Specialized Programs of Research Excellence (SPORE) and the Doris Duke Charitable Foundation.

Other UCLA authors include: Preston Crowell, Jenna Giafaglione, Anthony Jones, Nicholas Nunley, Takao Hashimoto, Amelie Delcourt, Anton Petcherski, Raag Agrawal, Matthew Bernard, Johnny Diaz, Kylie Heering, Rong Rong Huang, Nedas Matulionis, Huihui Ye, Heather Christofk, Matthew Rettig, Robert Reiter, Paul Boutros, Orian Shirihai and Ajit Divakaruni.



Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer

Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge. An international team of researchers from the Institute for Research in Biomedicine (IRB Barcelona), the Max Planck Institute for Molecular Genetics (MPIMG), BC Cancer (University of British Columbia) and other institutions has discovered a potential way to target the androgen receptor, the most prominent oncogenic transcription factor in prostate cancer, based on its propensity to form droplets also known as condensates. The results described ...

MD Anderson’s Katy Rezvani, M.D., receives 2023 Honorific Award from the American Society of Hematology

Katy Rezvani, M.D., Ph.D., professor of Stem Cell Transplantation & Cellular Therapy at The University of Texas MD Anderson Cancer Center, has been honored with the E. Donnall Thomas Lecture and Prize from the American Society of Hematology (ASH) for her groundbreaking research to develop and advance innovative cell therapies for cancer using natural killer (NK) cells. “I am fortunate to be able to engage in research that I am passionate about, to mentor incredible young scientists, and to collaborate with a remarkable team of researchers and clinicians. But most importantly, I am blessed to have the opportunity to undertake research that has the potential to ...

Salty immune cells surrounding the brain linked to hypertension-induced dementia

Salty immune cells surrounding the brain linked to hypertension-induced dementia
A study supported by the National Institutes of Health suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high blood pressure. This finding, published in Nature Neuroscience, may shed light on new ways to counteract the effects of high blood pressure on cognition. The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), a part of NIH. “The role of immune signaling in cognitive decline is critically important to understand,” said Roderick Corriveau, Ph.D., program director, NINDS. “These findings offer insight ...

Dark galactic region nicknamed "The Brick" explained with Webb telescope findings

In a recent study led by University of Florida astronomer Adam Ginsburg, groundbreaking findings shed light on a mysterious dark region at the center of the Milky Way. The turbulent gas cloud, playfully nicknamed “The Brick” due to its opacity, has sparked lively debates within the scientific community for years. To decipher its secrets, Ginsburg and his research team, including UF graduate students Desmond Jeff, Savannah Gramze, and Alyssa Bulatek, turned to the James Webb Space Telescope (JWST). The implications of their observations, published in ...

Awareness, accessibility, and affordability are crucial for the early detection of thalassemia

Awareness, accessibility, and affordability are crucial for the early detection of thalassemia
- Interviewing Dr. Androulla Eleftheriou, Executive Director at TIF, and Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation Thalassemia, a hereditary hemoglobinopathy, occurs in 4.4 out of every 10,000 live births and is prevalent in Mediterranean coastal areas, Africa, the Middle East, Southeast Asia, and southern China. Screening and antenatal diagnosis reduced the frequency of β-thalassemia in many Mediterranean countries. Focusing on other regions with high thalassemia prevalence, BGI Genomics has launched the Global 2023 State of Thalassemia Awareness Report, covering 1,847 ...

Complications from flu largely preventable with annual flu vaccine

ARLINGTON, Va., BETHESDA, Md., CHICAGO and DALLAS, Dec. 4, 2023 — During National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if they have not already done so. The flu is more than an inconvenience: it can lead to hospitalization, worsening of chronic medical conditions or even death. An annual flu vaccine is the best way to help prevent complications from the flu. [1] The American Heart Association®, the American Lung Association,® the American ...

Soil drought weakens forest microclimatic cooling

Soil drought weakens forest microclimatic cooling
Scientists from Stockholm University have investigated the mechanisms that create cool microclimates beneath forest canopies during warm and dry summer days. The study reveals how canopy shading and water evaporation together create cooler forest microclimates compared to temperatures outside forests. The article is published in Agricultural and Forest Meteorology. ”The findings are alarming in the context of climate change as more frequent and more severe droughts may threaten the cooling functions of forests,” says Caroline Greiser, researcher at the Physical Geography Department, Stockholm ...

Study shows advanced footwear technology positively impacts elite sprint performances

Study shows advanced footwear technology positively impacts elite sprint performances
A scientific study published in PeerJ Life & Environment sheds light on the potential game-changing impact of advanced footwear technology (AFT) on elite sprint performances in track and field. The research, titled "The Potential Impact of Advanced Footwear Technology on the Recent Evolution of Elite Sprint Performances," reveals the significant strides made in sprint performance and suggests that AFT has played a pivotal role in these improvements.    Elite track ...

What's behind the holiday-suicide myth

Whats behind the holiday-suicide myth
PHILADELPHIA – For more than two decades, the Annenberg Public Policy Center has tracked the ways in which news organizations erroneously link the year-end holiday season with suicide, perpetuating the false holiday-suicide myth. But as years of national data show, the winter holiday months usually have low average daily suicide rates, with December the lowest of all. In our new media analysis, we find that of the newspaper stories during the 2022-23 holiday season that explicitly connected the holidays with suicide, 60% correctly debunked the myth while 40% incorrectly supported it. But it’s not just the media that ...

More than a meteorite: New clues about the demise of dinosaurs

What wiped out the dinosaurs? A meteorite plummeting to Earth is only part of the story, a new study suggests. Climate change triggered by massive volcanic eruptions may have ultimately set the stage for the dinosaur extinction, challenging the traditional narrative that a meteorite alone delivered the final blow to the ancient giants. That’s according to a study published in Science Advances, co-authored by Don Baker, a professor in McGill University’s Department of Earth and Planetary Sciences. The research team delved into volcanic eruptions of the Deccan Traps—a ...


Small and overlooked: Amount of repetitive DNA in blood hints at cancer early

Study determines the original orientations of rocks drilled on Mars

Illinois study: Supporting disease-challenged broiler chickens through nutrition

Communities severed by roads and traffic experience a larger number of collisions in New York City

Study shows new class of antivirals that works against SARS-CoV-2

Cost of direct air carbon capture to remain higher than hoped

Unraveling the mystery of chiton visual systems

Case Western Reserve University-led research team discovers new method to test for oral cancer

Firearm access and gun violence exposure are common in Black and native communities

New AI smartphone tool accurately diagnoses ear infections

Screen time and parent-child talk when children are ages 12 to 36 months

Firearm access and gun violence exposure among American Indian or Alaska native and Black adults

Associations of medical debt with health status, premature death, and mortality in the US

Low-cost liquid tames tooth decay

More than 1/3 illicit drugs sold on the dark web contain unexpected substances

A better way to deliver fetal therapy for serious genetic disorders

Researchers develop amphibian-inspired camouflage skin

Network of quantum sensors boosts precision

Robotic hip exoskeleton shows promise for helping stroke patients regain their stride

Conservation value of field research stations grossly misunderstood and underfunded according to 173 conservation scientists in new study

Study underscores social factors of low breast cancer screening in the US

Nanomedicine research aims to transform treatment of aortic aneurysms

HIV medication can be used safely with gender-affirming hormone therapy

Gene-edited lymphocytes and the path toward ‘off-the-shelf’ therapy against cervical cancer

Humans have driven the Earth’s freshwater cycle out of its stable state

Exposure to different kinds of music influences how the brain interprets rhythm

Study shows differences in how patients with impulse control disorder process consequences

Improving access to early-stage lung cancer care in Europe

Low iron levels resulting from infection could be key trigger of long COVID

Swapping meat for Quorn lowers bad cholesterol by 10-percent

[] Studies help explain why some prostate cancers become resistant to hormone therapy
UCLA-led research lays the groundwork for developing improved therapies for treatment-resistant prostate tumors